Renaissance Technologies (RenTech)'s TENX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 164,000 shares of Tenax Therapeutics, Inc. (TENX) worth $2.39 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TENX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 68,979 shares. Largest reduction occurred in Q2 2021, reducing 347 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Tenax Therapeutics (TENX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenax Therapeutics (TENX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +11,400 | Add 7.47% | 164,000 | $14.55 |
| Q1 2026 | +27,021 | Add 21.52% | 152,600 | $15.99 |
| Q4 2025 | +68,979 | Add 121.87% | 125,579 | $12.19 |
| Q3 2025 | +56,600 | New Buy | 56,600 | $7.61 |
| Q1 2023 | -40 | Sold Out | 0 | $0.00 |
| Q4 2022 | -49 | Reduce 55.06% | 40 | $0.18 |
| Q3 2022 | +48 | Add 117.07% | 89 | $269.66 |
| Q2 2022 | -1 | Reduce 2.38% | 41 | $487.80 |
| Q1 2022 | -8 | Reduce 16.00% | 42 | $1309.52 |
| Q4 2021 | -14 | Reduce 21.88% | 50 | $1680.00 |
| Q3 2021 | -56 | Reduce 46.67% | 64 | $2843.75 |
| Q2 2021 | -347 | Reduce 74.30% | 120 | $3333.33 |
| Q1 2021 | +200 | Add 74.91% | 467 | $3042.83 |
| Q4 2020 | -63 | Reduce 19.09% | 267 | $2973.78 |
| Q3 2020 | -116 | Reduce 26.01% | 330 | $2460.61 |
| Q2 2020 | +83 | Add 22.87% | 446 | $1448.43 |
| Q1 2020 | +83 | Add 29.64% | 363 | $914.60 |
| Q4 2019 | +24 | Add 9.38% | 280 | $2257.14 |
| Q3 2019 | +31 | Add 13.78% | 256 | $1917.97 |
| Q2 2019 | +74 | Add 49.01% | 225 | $2204.44 |
| Q1 2019 | +48 | Add 46.60% | 151 | $3238.41 |
| Q4 2018 | +48 | Add 87.27% | 103 | $1932.04 |
| Q3 2018 | +3 | Add 5.77% | 55 | $8381.82 |
| Q2 2018 | +16 | Add 44.44% | 52 | $10115.38 |
| Q1 2018 | +36 | New Buy | 36 | $8694.44 |
Renaissance Technologies (RenTech)'s Tenax Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Tenax Therapeutics, Inc. (TENX) in Q1 2018, acquiring 36 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Tenax Therapeutics, Inc. (TENX) for 25 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Tenax Therapeutics, Inc. (TENX) was in Q4 2025, adding 125,579 shares worth $1.53 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 164,000 shares of Tenax Therapeutics, Inc. (TENX), valued at approximately $2.39 M.
As of the Q2 2026 filing, Tenax Therapeutics, Inc. (TENX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Tenax Therapeutics, Inc. (TENX) was 164,000 shares, as reported at the end of Q2 2026.